CAREER MOBILITY IN ITALY: THE CASE OF CONSTRUCTION WORKERSPASQUALINI R.INFORM. SCI. SOC. 1972, Vol 11, Num 5, pp 313-319Article

TECHNOLOGIE DU GENERATEUR DE ^99MTC, ELUMATIC III DU COMMISSARIAT A L'ENERGIE ATOMIQUE, FRANCELE BRIS H; PASQUALINI R; REBOUL J et al.1982; INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES; ISSN 0020-708X; USA; DA. 1982; VOL. 33; NO 10; PP. 821-827; H.T. 2; ABS. ENG; BIBL. 10 REF.Article

Organ targeting in vivo using phage display peptide librariesPASQUALINI, R; RUOSLAHTI, E.Nature (London). 1996, Vol 380, Num 6572, pp 364-366, issn 0028-0836Article

METABOLIC CLEARANCE RATE OF RADIOIODINATED ANGIOTENSIN II IN NORMAL MEN = TAUX DE CLEARANCE METABOLIQUE DE L'ANGIOTENSINE II MARQUEE A L'IODE RADIOACTIF CHEZ L'HOMME NORMALDONATO L; COLI A; PASQUALINI R et al.1972; AMER. J. PHYSIOL.; U.S.A.; DA. 1972; VOL. 223; NO 5; PP. 1250-1256; BIBL. 25 REF.Article

Contrasting roles for integrin β₁ β₅ cytoplasmic domains in subcellular localization, cell proliferation, and cell migrationPASQUALINI, R; HEMLER, M. E.The Journal of cell biology. 1994, Vol 125, Num 2, pp 447-460, issn 0021-9525Article

Tumor targeting with a selective gelatinase inhibitorKOIVUNEN, E; ARAP, W; SORSA, T et al.Nature biotechnology. 1999, Vol 17, Num 8, pp 768-774, issn 1087-0156Article

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse modelARAP, W; PASQUALINI, R; RUOSLAHTI, E et al.Science (Washington, D.C.). 1998, Vol 279, Num 5349, pp 377-380, issn 0036-8075Article

αv Integrins as receptors for tumor targeting by circulating ligandsPASQUALINI, R; KOIVUNEN, E; RUOSLAHTI, E et al.Nature biotechnology. 1997, Vol 15, Num 6, pp 542-546, issn 1087-0156Article

Interaction of Technetium-99m-N-NOET with blood elements : Potential mechanism of myocardial redistributionJOHNSON, G. III; NGUYEN, K. N; PASQUALINI, R et al.The Journal of nuclear medicine (1978). 1997, Vol 38, Num 1, pp 138-143, issn 0161-5505Article

A study of the structure, function and distribution of β₅ integrins using novel anti-β₅ monoclonal antibodiesPASQUALINI, R; BODOROVA, J; SONG YE et al.Journal of Cell Science. 1993, Vol 105, pp 101-111, issn 0021-9533, 1Article

Labeling of ethambutol with ⁹⁹mTc using a new reduction procedure. Pharmacokinetic study in the mouse and ratCAUSSE, J. E; PASQUALINI, R; CYPRIANI, B et al.Applied radiation and isotopes. 1990, Vol 41, Num 5, pp 493-496, issn 0969-8043, 4 p.Article

Determination of the putative binding site for fibronectin on platelet glycoprotein IIb-IIIa complex through a hydropathic complementarity approachPASQUALINI, R; CHAMONE, D. F; BRENTANI, R. R et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 24, pp 14566-14570, issn 0021-9258, 5 p.Article

Tecnetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of [Tc≡N]²⁺ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of [S-methyl 3-(2-hydroxyphenyl-methylene)dithiocarbazato]nitrido(triphenylphosphine)technetium(V) and bis(S-methyl 3-isopropylidenedithiocarbazato)nitridotechnetium(V)MARCHI, A; DUATTI, A; ROSSI, R et al.Journal of the Chemical Society. Dalton transactions. 1988, Num 7, pp 1743-1749, issn 0300-9246Article

Synthese de nouveaux sels tetraphosphonium macrocycliques = Synthesis of new macrocyclic tetraphosphonium saltsVINCENS, M; MORON, J. T. G; PASQUALINI, R et al.Tetrahedron letters. 1987, Vol 28, Num 12, pp 1259-1262, issn 0040-4039Article

Spore-forming bacteria in commercial cooked, pasteurised and chilled vegetable puréesCARLIN, F; GUINEBRETIERE, M.-H; CHOMA, C et al.Food microbiology. 2000, Vol 17, Num 2, pp 153-165, issn 0740-0020Article

Biodistribution, dosimetry, and Safety of myocardial perfusion imaging agent ^99mTcN-NOET in healthy volunteersVANZETTO, G; FAGRET, D; PASQUALINI, R et al.The Journal of nuclear medicine (1978). 2000, Vol 41, Num 1, pp 141-148, issn 0161-5505Article

Cellular uptake mechanisms of ^99mTcN-NOET in cardiomyocytes from newborn rats : Calcium channel interactionRIOU, L; GHEZZI, C; MOUTON, O et al.Circulation (New York, N.Y.). 1998, Vol 98, Num 23, pp 2591-2597, issn 0009-7322Article

Mécanismes de fixation cellulaire de TCN-NOET, un nouveau traceur de la perfusion myocardique = Cellular uptake mechanisms of TCN-NOET, a new myocardial perfusion imaging agentRIOU, L; GHEZZI, C; MOUTON, O et al.Innovation et technologie en biologie et médecine. 1998, Vol 19, Num 6, pp 439-447, issn 0243-7228Article

Influence of a ^99mTcN core on the biological and physicochemical behavior of ^99mTc complexes of L,L-EC and L,L-ECDMANG'ERA, K. O; VANBILLOEN, H. P; BELLANDE, E et al.Nuclear medicine and biology. 1996, Vol 23, Num 8, pp 987-993, issn 0969-8051Article

Targeted disruption of CD43 gene enhances T lymphocyte adhesionMANJUNATH, N; JOHNSON, R. S; STAUNTON, D. E et al.The Journal of immunology (1950). 1993, Vol 151, Num 3, pp 1528-1534, issn 0022-1767Article

A new efficient method for the preparation of ^99mTc-radiopharmaceuticals containings the Tc≡N multiple bondPASQUALINI, R; COMAZZI, V; BELLANDE, E et al.International journal of radiation applications and instrumentation. Part A. Applied radiation and isotopes. 1992, Vol 43, Num 11, pp 1329-1333, issn 0883-2889Article

Direct ^99mTc labeling of monoclonal antibodies : radiolabeling and in vitro stabilityGARRON, J. Y; MOINEREAU, M; PASQUALINI, R et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 7, pp 695-703, issn 0883-2897Article

Synthèse de dithioétherdithiols, complexants potentiels du technétium. Résultats obtenus = Synthesis of dithioetherdithiols, potentiel technetium complexing agentsALAGUI, A; APPARU, M; PASQUALINI, R et al.Bulletin de la Société chimique de France. 1991, Num 2, pp 286-295, issn 0037-8968Article

Characterization of the cellular receptor for fibronectin through a hydropathic complementarity approachBRENTANI, R. R; RIBEIRO, S. F; POTOCNJAK, P et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 2, pp 364-367, issn 0027-8424Article

A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formationLIN, S.-H; CHENG, C.-J; HU, M et al.Oncogene (Basingstoke). 2008, Vol 27, Num 39, pp 5195-5203, issn 0950-9232, 9 p.Article